Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities – cross-sectional study of the general population
Background We aimed to assess whether we could identify a graded association between increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities independently of predicted risk of coronary heart disease by the Framingham risk score. Methods We conducted a cross-sectional study on a random sample of the urban population of Porto aged 45 years or over. Six hundred and eighty-four participants were included. Data were collected by a structured clinical interview with a physician, ECG and a transthoracic M-mode and 2D echocardiogram. The metabolic syndrome was defined according to ATPIII-NCEP. The association between the number of features of the metabolic syndrome and the cardiac structural and functional abnormalities was assessed by 3 multivariate regression models: adjusting for age and gender, adjusting for the 10-year predicted risk of coronary heart disease by Framingham risk score and adjusting for age, gender and systolic blood pressure. Results There was a positive association between the number of features of metabolic syndrome and parameters of cardiac structure and function, with a consistent and statistically significant trend for all cardiac variables considered when adjusting for age and gender. Parameters of left ventricular geometry patterns, left atrial diameter and diastolic dysfunction maintained this trend when taking into account the 10-year predicted risk of coronary heart disease by the Framingham score as an independent variable, while left ventricular systolic dysfunction did not. The prevalence of left ventricular diastolic dysfunction, and the mean left ventricular mass, left ventricular diameter and left atrial diameter increased significantly with the number of features of the metabolic syndrome when additionally adjusting for systolic blood pressure as a continuous variable. Conclusion Increasing severity of metabolic syndrome was associated with increasingly compromised structure and function of the heart. This association was independent of Framingham risk score for indirect indices of diastolic dysfunction but not systolic dysfunction, and was not explained by blood pressure level..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
BMC cardiovascular disorders - 7(2007), 1 vom: 07. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Azevedo, Ana [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Coronary Heart Disease |
|---|
| Anmerkungen: |
© Azevedo et al; licensee BioMed Central Ltd. 2007 |
|---|
| doi: |
10.1186/1471-2261-7-17 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR02733080X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR02733080X | ||
| 003 | DE-627 | ||
| 005 | 20230519235139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2261-7-17 |2 doi | |
| 035 | |a (DE-627)SPR02733080X | ||
| 035 | |a (SPR)1471-2261-7-17-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Azevedo, Ana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities – cross-sectional study of the general population |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Azevedo et al; licensee BioMed Central Ltd. 2007 | ||
| 520 | |a Background We aimed to assess whether we could identify a graded association between increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities independently of predicted risk of coronary heart disease by the Framingham risk score. Methods We conducted a cross-sectional study on a random sample of the urban population of Porto aged 45 years or over. Six hundred and eighty-four participants were included. Data were collected by a structured clinical interview with a physician, ECG and a transthoracic M-mode and 2D echocardiogram. The metabolic syndrome was defined according to ATPIII-NCEP. The association between the number of features of the metabolic syndrome and the cardiac structural and functional abnormalities was assessed by 3 multivariate regression models: adjusting for age and gender, adjusting for the 10-year predicted risk of coronary heart disease by Framingham risk score and adjusting for age, gender and systolic blood pressure. Results There was a positive association between the number of features of metabolic syndrome and parameters of cardiac structure and function, with a consistent and statistically significant trend for all cardiac variables considered when adjusting for age and gender. Parameters of left ventricular geometry patterns, left atrial diameter and diastolic dysfunction maintained this trend when taking into account the 10-year predicted risk of coronary heart disease by the Framingham score as an independent variable, while left ventricular systolic dysfunction did not. The prevalence of left ventricular diastolic dysfunction, and the mean left ventricular mass, left ventricular diameter and left atrial diameter increased significantly with the number of features of the metabolic syndrome when additionally adjusting for systolic blood pressure as a continuous variable. Conclusion Increasing severity of metabolic syndrome was associated with increasingly compromised structure and function of the heart. This association was independent of Framingham risk score for indirect indices of diastolic dysfunction but not systolic dysfunction, and was not explained by blood pressure level. | ||
| 650 | 4 | |a Coronary Heart Disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Metabolic Syndrome |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diastolic Dysfunction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Framingham Risk Score |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Functional Abnormality |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Bettencourt, Paulo |4 aut | |
| 700 | 1 | |a Almeida, Pedro B |4 aut | |
| 700 | 1 | |a Santos, Ana C |4 aut | |
| 700 | 1 | |a Abreu-Lima, Cassiano |4 aut | |
| 700 | 1 | |a Hense, Hans-Werner |4 aut | |
| 700 | 1 | |a Barros, Henrique |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cardiovascular disorders |d London : BioMed Central, 2001 |g 7(2007), 1 vom: 07. Juni |w (DE-627)SPR027329267 |w (DE-600)2059859-2 |x 1471-2261 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2007 |g number:1 |g day:07 |g month:06 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/1471-2261-7-17 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2007 |e 1 |b 07 |c 06 | ||